Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Braun

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Cancer Research|July 15, 1993
Sensitivity of tumoricidal function in macrophages from different anatomical sites of cancer patients to modulation of arachidonic acid metabolismD P Braun, M C Ahn, J E Harris, et al.
Cancer Research|November 15, 1988
Appearance and phenotypic characterization of circulating Leu 19+ cells in cancer patients receiving recombinant interleukin 2T M Ellis, S P Creekmore, J D McMannis, et al.
Cancer Immunology, Immunotherapy : CII|November 14, 1997
Modulation of tumoricidal function in alveolar macrophages from lung cancer patients by interleukin-6M C Ahn, K P Siziopikou, J M Plate, et al.
Journal of Biological Response Modifiers|January 1, 1983
Effect of interferon therapy on indomethacin-sensitive immunoregulation in the peripheral blood mononuclear cells of renal cell carcinoma patientsD P Braun, Z L Harris, J E Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
A phase I clinical trial of recombinant interleukin-2 by periodic 24-hour intravenous infusionsS P Creekmore, J E Harris, T M Ellis, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Cancer Research|July 15, 1993
Sensitivity of tumoricidal function in macrophages from different anatomical sites of cancer patients to modulation of arachidonic acid metabolismD P Braun, M C Ahn, J E Harris, et al.
Cancer Research|November 15, 1988
Appearance and phenotypic characterization of circulating Leu 19+ cells in cancer patients receiving recombinant interleukin 2T M Ellis, S P Creekmore, J D McMannis, et al.
Cancer Immunology, Immunotherapy : CII|November 14, 1997
Modulation of tumoricidal function in alveolar macrophages from lung cancer patients by interleukin-6M C Ahn, K P Siziopikou, J M Plate, et al.
Journal of Biological Response Modifiers|January 1, 1983
Effect of interferon therapy on indomethacin-sensitive immunoregulation in the peripheral blood mononuclear cells of renal cell carcinoma patientsD P Braun, Z L Harris, J E Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
A phase I clinical trial of recombinant interleukin-2 by periodic 24-hour intravenous infusionsS P Creekmore, J E Harris, T M Ellis, et al.
Pageof 6